Wearable Injectors Market Size

Wearable Injectors Market Size

Wearable Injectors Market size was worth USD 8 billion in 2022 and will progress at over 13.5% CAGR from 2023 to 2032. The industry demand is fueled by the growing prevalence of chronic diseases, including immunological disorders, diabetes, cardiovascular diseases, and cancer, among others.

To get key market trends

  Download Free Sample

For instance, as per the International Diabetes Federation, around 537 million people were suffering from diabetes in 2021, which is further projected to exceed 643 million by 2030. Patients suffering from several chronic conditions often require long-term treatment, and wearable injectors offer a convenient and less invasive way to administer medication.

Wearable injectors are drug-delivery devices that adhere to the body and automatically deliver set doses of medication to the patient at optimal times. They offer many benefits to the user and drug manufacturers, including precise dosing, ease of use, adherence, and tracking capabilities. Moreover, the increasing number of government initiatives for the treatment and prevention of chronic ailments, such as cancer, diabetes, and cardiovascular diseases, in homecare facilities to combat the rising chronic disease burden will boost the industry progress.

Despite a positive outlook for the wearable injectors market, the preference for alternative drug delivery systems is negatively impacting industry revenue. The ability to improve patient compliance and convenience offered by alternative systems is restraining product utilization. High adoption of traditional drug delivery methods, such as intravenous injections and oral medications due to a dearth of awareness associated with advanced delivery systems is affecting overall market demand. However, growing awareness regarding advanced non-invasive drug delivery methods for long-term treatment among several nations is anticipated to accelerate the market trends.